浙江震元(000705.SZ)及子公司獲得藥品經營許可證和藥品GSP證書
格隆匯12月4日丨浙江震元(000705.SZ)公佈,公司和子公司紹興震元醫藥有限公司(“震元醫藥”)日前收到浙江省藥品監督管理局核發的《藥品經營許可證》和《藥品經營質量管理規範認證證書》(即《藥品GSP證書》)。
一、《藥品經營許可證》
1、浙江震元股份有限公司
經營範圍:中藥材、中藥飲片、中成藥、化學藥製劑、化學原料藥、抗生素製劑、抗生素原料藥、生化藥品、生物製品、麻醉藥品、精神藥品(第一類、第二類)、蛋白同化製劑、肽類激素、醫療用毒性藥品(以上經營範圍委託浙江震元物流有限公司儲存和配送)***;有效期至:2024年11月26日
2、浙江震元股份有限公司紹興藥材分公司
經營範圍:中藥材、中藥飲片、中成藥、醫療用毒性藥品(以上經營範圍委託浙江震元物流有限公司儲存和配送)***;有效期至:2024年11月26日
3、紹興震元醫藥經營有限責任公司
經營範圍:中成藥、化學藥製劑、化學原料藥、抗生素製劑、抗生素原料藥、生化藥品、生物製品、體外診斷試劑、蛋白同化製劑、肽類激素***;有效期至:2024年11月26日
二、《藥品經營質量管理規範認證證書》
1、浙江震元股份有限公司
認證範圍:藥品批發;有效期至:2024年11月26日
2、紹興震元醫藥經營有限責任公司
認證範圍:藥品批發;有效期至:2024年11月26日
此次公司、藥材分公司及子公司震元醫藥取得《藥品經營許可證》、公司及子公司震元醫藥取得《藥品GSP證書》,表明公司、分公司及子公司震元醫藥的質量管理體系符合《藥品經營質量管理規範》的要求,其質量管理體系進一步完善,有利於促進其藥品經營業務的持續開展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.